Current Progress in iPSC Disease Modeling, Volume Fourteen in the Advances in Stem Cell Biology series, is a timely and expansive collection of information and new discoveries in the field. This new volume addresses advances in research on how induced pluripotent stem cells are used for the creation of new tissues and organs. The creation of iPSC technology allowed the development of disease-specific human pluripotent stem cells. These cells allow researchers to study questions once impossible for some human diseases. This volume addresses iPSCs for vascular tissue engineering, bioprinting, derived lung organoids for pulmonary disorders, skeletal muscle engineering, human kidney organoids, and more.
It is written for researchers and scientists in stem cell therapy, cell biology, regenerative medicine and organ transplantation, and is contributed by world-renowned authors in the field.
1. Current Progress in iPSC Disease Modeling, Volume 14 - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page ii 4. Table of Contents - p. Page iii 5. Advances in Stem Cell Biology - p. Page iv 6. Copyright - p. Page v 7. Dedication - p. Page vi 8. Contributors - p. Page vi 9. About the editor - p. Page x 10. Preface - p. Page x 11. List of Illustrations - p. Page xii 12. List of Tables - p. Page xiii 13. Chapter 1 : Human induced pluripotent stem cell modeling of neurofibromatosis type 1 - p. Page xiii 14. Chapter 2 : Use of induced pluripotent stem cells to model inflammatory neurodegeneration and repair in multiple sclerosis - p. Page 14 15. Chapter 3 : Induced pluripotent stem cell technology to model chronic mountain sickness - p. Page 41 16. Chapter 4 : Induced pluripotent stem cells for modeling Noonan, Noonan Syndrome with Multiple Lentigines, and Costello Syndromes - p. Page 58 17. Chapter 5 : Modeling mitochondrial encephalopathy due to MELAS/Leigh overlap syndrome using induced pluripotent stem cells - p. Page 97 18. Chapter 6 : How induced pluripotent stem cells changed the research status of polycystic ovary syndrome - p. Page 123 19. Chapter 7 : Modeling inherited retinal dystrophies using induced pluripotent stem cells - p. Page 145 20. Chapter 8 : Modeling hereditary spastic paraplegias using induced pluripotent stem cells - p. Page 173 21. Chapter 9 : Induced pluripotent stem cells for modeling Smith–Magenis syndrome - p. Page 206 22. Chapter 10 : Induced pluripotent stem cells for modeling of cardiac arrhythmias - p. Page 240 23. Chapter 11 : Modeling heritable kidney disease using human kidney iPSC-derived organoids - p. Page 264 24. Index - p. Page 290
Current Progress in iPSC Disease Modeling, Volume Fourteen in the Advances in Stem Cell Biology series, is a timely and expansive collection of information and new discoveries in the field. This new volume addresses advances in research on how induced pluripotent stem cells are used for the creation of new tissues and organs. The creation of iPSC technology allowed the development of disease-specific human pluripotent stem cells. These cells allow researchers to study questions once impossible for some human diseases. This volume addresses iPSCs for vascular tissue engineering, bioprinting, derived lung organoids for pulmonary disorders, skeletal muscle engineering, human kidney organoids, and more.
It is written for researchers and scientists in stem cell therapy, cell biology, regenerative medicine and organ transplantation, and is contributed by world-renowned authors in the field.
1. Current Progress in iPSC Disease Modeling, Volume 14 - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page ii 4. Table of Contents - p. Page iii 5. Advances in Stem Cell Biology - p. Page iv 6. Copyright - p. Page v 7. Dedication - p. Page vi 8. Contributors - p. Page vi 9. About the editor - p. Page x 10. Preface - p. Page x 11. List of Illustrations - p. Page xii 12. List of Tables - p. Page xiii 13. Chapter 1 : Human induced pluripotent stem cell modeling of neurofibromatosis type 1 - p. Page xiii 14. Chapter 2 : Use of induced pluripotent stem cells to model inflammatory neurodegeneration and repair in multiple sclerosis - p. Page 14 15. Chapter 3 : Induced pluripotent stem cell technology to model chronic mountain sickness - p. Page 41 16. Chapter 4 : Induced pluripotent stem cells for modeling Noonan, Noonan Syndrome with Multiple Lentigines, and Costello Syndromes - p. Page 58 17. Chapter 5 : Modeling mitochondrial encephalopathy due to MELAS/Leigh overlap syndrome using induced pluripotent stem cells - p. Page 97 18. Chapter 6 : How induced pluripotent stem cells changed the research status of polycystic ovary syndrome - p. Page 123 19. Chapter 7 : Modeling inherited retinal dystrophies using induced pluripotent stem cells - p. Page 145 20. Chapter 8 : Modeling hereditary spastic paraplegias using induced pluripotent stem cells - p. Page 173 21. Chapter 9 : Induced pluripotent stem cells for modeling Smith–Magenis syndrome - p. Page 206 22. Chapter 10 : Induced pluripotent stem cells for modeling of cardiac arrhythmias - p. Page 240 23. Chapter 11 : Modeling heritable kidney disease using human kidney iPSC-derived organoids - p. Page 264 24. Index - p. Page 290
